biotech radar UNIVERSE

Companies Covered in our Universe

Company Visual Identity Country Listing
last update: 14/01/2023 - logos are registered and/or protected by the copyright of the respective companies


Deal Monitor – European Public Biotech Companies

Data as of 27/01/2023.


Financing Monitor – European Public Biotech Companies

Data as of 27/01/2023.

Latest News

DATA & INTEL FOR A 360° View on the Public Biotech Landscape in Europe

How We Help Investors & Professionals in Life Sciences
DISCOVER NEW COMPANIES WITH OUR BROAD COVERAGE

Our data coverage is focused on the European biotech companies listed on the main stock exchange platforms in 13 countries: Germany, France, Belgium, Netherlands, Switzerland, UK, Ireland, Spain, Italy and the Nordic countries (Denmark, Sweden, Norway, Finland). The coverage only includes biotech companies developping therapeutics, we DO NOT COVER: pharma companies, the medtech landscape, nor the associated service companies (CRO, CMO, Drug Discovery, etc…), with few exceptions nevertheless. We include some potentially high-growth companies in the field of diagnostics, as well as some specialty companies.

ACCESS INSIGHTS, GAIN TIME, SPOT OPPORTUNITIES

We provide timely detailed data on the pipeline of all the companies, representing more than 1200 programs currently at the clinical stage (more than 2000 programs overall). Our service is both a discovery tool for potential new opportunities, and a platform tracking any event from the covered companies. It may also be seen as a promoting support for this universe, even though we are completely independent. Maximize knowledge in a short period, and gain a tremendous amount of time in your due dilligence and research process. We do not cover the scientific analysis part (results from clinical trials).

FINANCIAL DATA, MARKET DATA, DEALS, FINANCINGS…

We provide up-to-date relevant financial data on the companies: cash positions, cash burn rates, live cash estimates, cash runways, income statements. Don’t get lost in the numerous financing schemes with our detailed tracking of the financing lines (as much as decently possible). Access our database of financing agreements, parse our records of the various partnerships between the companies and third parties. Keep track of the stocks on our free dashboards (disclaimers apply), and more.

INDICATORS AND ANALYTICS (IN DEVELOPMENT)

We will strive to deliver specific insights on the public European biotech landscape by leveraging our large -and still growing- set of data. We aim to provide intelligence, highlighting dynamics, as well as identifying trends in various relevant areas. We will also provide a picture of the landscape periodically. Some analysis may be published in the form of reports, reserved to our clients or made public. We will also develop indicators thought to be specifically relevant for investors.


Data from 13 Countries, 10 Languages, 8 European Equity Markets, 7 Currencies

Check out our introductory review

2018 Review European Biotech

Biotech Radar Service

All in one place, for PROs only
biotechradar.eu,
European hub for investors and professionnals
in Life Sciences

Our Service covers the pipeline, the commercial products (therapeutics only), the financials, the deals, the financing operations of the European public biotech companies, and more.
The market data can be accessed for free.
We DO NOT provide any recommendations on any financial instruments. We own our data and we collect them from corporate or well-trusted sources (e.g. clinicaltrials.gov). We operate as an independent company.

  • Pipeline

    All the programs, all the product candidates & all the commercial products

  • Financials

    All the main financial figures

  • Market Data

    in our coverage universe

  • Deals & Financing

    Deal DB, Financing DB

error: